Skip to main content
CALQUENCE 100 mg/1 tablet, film coated by AstraZeneca Pharmaceuticals LP
CALQUENCE, 100 mg/1, tablet, film coated Drug class: Kinase Inhibitor. Available on prescription only. Listed by AstraZeneca Pharmaceuticals LP.
Prescription only

CALQUENCE

acalabrutinib

Listed by AstraZeneca Pharmaceuticals LP

Strength
100 mg/1
Form
Tablet, Film Coated
Route
Oral
Class
Kinase Inhibitor

What it contains

  • Acalabrutinib 100 mg/1

FDA record

Dosage form Tablet, Film Coated
Route Oral
Drug class Kinase Inhibitor
Approval route NDA — original brand approval
NDC code 0310-3512
FDA application NDA216387
RxNorm concept 2607734
Package sizes listed 2
Marketed since August 2022

Other products containing Acalabrutinib

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

CALQUENCE

acalabrutinib

Strength
100 mg/1
Form
Tablet, Film Coated
Class
Kinase Inhibitor
Rx only

AstraZeneca Pharmaceuticals LP

$543.38 We supply Acaone 100 mg (1 bottle / 30 caps) View product

CALQUENCE

Acalabrutinib

Strength
100 mg/1
Form
Capsule, Gelatin Coated
Class
Kinase Inhibitor
Rx only

AstraZeneca Pharmaceuticals LP

$543.38 We supply Acaone 100 mg (1 bottle / 30 caps) View product

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.